Kaushal Parikh, M.B.B.S.

  1. Oncologist
  1. Fletcher K, Machaalani M, El Hajj Chehade R, Nassar AH, Nawfal R, Manos M, Menzies AM, Aboubakar-Nana F, Hassel JC, Pinato DJ, Johnson A, Olsson-Brown AC, Carlino MS, Malgeri A, Cortellini A, Singh A, Parikh K, Kim SY, Naqash AR, Long GV, Challa P, Choueiri TK, Sharon E, Shah S, Johnson DB. Immune Checkpoint Inhibitors for Patients With Preexisting Autoimmune Neurologic Disorders. JAMA Netw Open. 2025 Jun 2; 8 (6):e2513727 Epub 2025 June 02
    View PubMed
  2. Voruganti T, Marar R, Bleiberg B, Garbo E, Ricciuti B, Parikh K, Aggarwal C. Perioperative Therapy in Oncogene-Driven Non-Small Cell Lung Cancer: Current Strategies and Unanswered Questions. Am Soc Clin Oncol Educ Book. 2025 Jun; 45 (3):e472804 Epub 2025 May 01
    View PubMed
  3. Singh A, Sridhar A, Poddar A, Dimou A, Parikh K, Shanshal M, Schwecke A, Moffett N, Patel MR, Mansfield AS, Leventakos K. Combination of Lurbinectedin and Osimertinib for Treatment of EGFR-Mutated Transformed SCLC: A Brief Report. JTO Clin Res Rep. 2025 Jun; 6 (6):100807 Epub 2025 Feb 13
    View PubMed
  4. Tavernari D, Borgeaud M, Liu X, Parikh K, Le X, Ciriello G, Addeo A. Decoding the Clinical and Molecular Signatures of EGFR Common, Compound, and Uncommon Mutations in NSCLC: A Brief Report. J Thorac Oncol. 2025 Apr; 20 (4):500-506 Epub 2024 Dec 16
    View PubMed
  5. Nassar AH, Abou Alaiwi S, El Zarif T, Denu R, Macaron W, Abdel-Wahab N, Freeman D, Vasbinder A, Hayeck S, Anderson E, Goodman RS, Johnson DB, Grynberg S, Shapira R, Kwan JM, Woodford R, Long GV, Haykal T, Dent S, Kojima Y, Yonemor K, Tandon A, Trevino A, Akhter N, Yang EH, Hui G, Drakaki A, El-Am E, Kozaily E, Al-Hader A, Bou Farhat E, Babu P, Mittra A, Li M, Jones N, Baena J, Juarez Herrera M, Foderaro S, Nana FA, Kim C, Sackstein P, Parikh K, Desai AP, Smith C, Cortellini A, Pinato DJ, Korolewicz J, Lopetegui-Lia N, Funchain P, Choudhary A, Asnani A, Navani V, Meyers D, Stukalin I, Ocejo Gallegos JA, Trent J, Nusrat S, Malvar C, McKay RR, Neilan TG, Choueiri TK, Naqash AR. Safety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: a multicenter international retrospective study. J Immunother Cancer. 2025 Mar 3; 13 (3) Epub 2025 Mar 03
    View PubMed
  6. Uprety D, Seaton R, Niroula A, Hadid T, Parikh K, Ruterbusch JJ. Trends in the Incidence and Survival Outcomes in Patients With Small Cell Lung Cancer in the United States: An Analysis of the SEER Database. Cancer Med. 2025 Feb; 14 (3):e70608
    View PubMed
  7. Mina SA, Shanshal M, Leventakos K, Parikh K. Emerging Targeted Therapies in Non-Small-Cell Lung Cancer (NSCLC). Cancers (Basel). 2025 Jan 22; 17 (3)
    View PubMed
  8. Nassar AH, Jayakrishnan R, Feng J, Shepherd F, Adib E, Cheung JM, Lin JJ, Liu Y, Lin SH, Parikh K, Sridhar A, Shakya P, Dilling TJ, Kaldas D, Gray JE, Lobachov A, Bar J, Luders H, Grohe C, Gupta S, Leal T, Fitzgerald B, Crowley F, Fujiwara Y, Marron TU, Wilgucki M, Reuss J, Chen L, Sankar K, Aredo JV, Neal JW, Wakelee HA, Thummalapalli R, Yu H, Whitaker R, Velazquez A, Ragavan M, Cortellini A, Kwiatkowski DJ, Naqash AR, Goldberg SB, Kim SY. Consolidation ALK Tyrosine Kinase Inhibitors Versus Durvalumab or Observation After Chemoradiation in Unresectable Stage III ALK-Positive NSCLC. J Thorac Oncol. 2025 Jan; 20 (1):109-118 Epub 2024 Sept 10
    View PubMed
  9. Parikh K, Harris FR, Karagouga G, Schrandt A, Mandrekar J, Johnson S, McCune A, Sadeghian D, Roy D, Polonis K, Gaitatzes A, Bungum AO, Edell ES, Borad MJ, Peikert T, Kosari F, Cheville J, Vasmatzis G, Mansfield AS. Individualized Cell-Free DNA Monitoring With Chromosomal Junctions for Mesothelioma. JTO Clin Res Rep. 2024 Dec; 5 (12):100692 Epub 2024 May 18
    View PubMed
  10. Parikh K, Dimou A, Leventakos K, Mansfield AS, Shanshal M, Wan Y, Lin HM, Vincent S, Elliott J, Bonta IR. Impact of EML4-ALK Variants and Co-Occurring TP53 Mutations on Duration of First-Line ALK Tyrosine Kinase Inhibitor Treatment and Overall Survival in ALK Fusion-Positive NSCLC: Real-World Outcomes From the GuardantINFORM database. J Thorac Oncol. 2024 Nov; 19 (11):1539-1549 Epub 2024 July 15
    View PubMed
  11. Borgeaud M, Parikh K, Banna GL, Kim F, Olivier T, Le X, Addeo A. Unveiling the Landscape of Uncommon EGFR Mutations in NSCLC-A Systematic Review. J Thorac Oncol. 2024 Jul; 19 (7):973-983 Epub 2024 Mar 16
    View PubMed
  12. Nassar AH, Kim SY, Aredo JV, Feng J, Shepherd F, Xu C, Kaldas D, Gray JE, Dilling TJ, Neal JW, Wakelee HA, Liu Y, Lin SH, Abuali T, Amini A, Nie Y, Patil T, Lobachov A, Bar J, Fitzgerald B, Fujiwara Y, Marron TU, Thummalapalli R, Yu H, Owen DH, Sharp J, Farid S, Rocha P, Arriola E, D'Aiello A, Cheng H, Whitaker R, Parikh K, Ashara Y, Chen L, Sankar K, Harris JP, Nagasaka M, Ayanambakkam A, Velazquez AI, Ragavan M, Lin JJ, Piotrowska Z, Wilgucki M, Reuss J, Luders H, Grohe C, Baena Espinar J, Feiner E, Punekar SR, Gupta S, Leal T, Kwiatkowski DJ, Mak RH, Adib E, Naqash AR, Goldberg SB. Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study. J Thorac Oncol. 2024 Jun; 19 (6):928-940 Epub 2024 Jan 24
    View PubMed
  13. Mitchell MI, Ben-Dov IZ, Ye K, Liu C, Shi M, Sadoughi A, Shah C, Siddiqui T, Okorozo A, Gutierrez M, Unawane R, Biamonte L, Parikh K, Spivack S, Loudig O. Exhaled breath condensate contains extracellular vesicles (EVs) that carry miRNA cargos of lung tissue origin that can be selectively purified and analyzed. J Extracell Vesicles. 2024 Apr; 13(4):e12440.
    View PubMed
  14. Nassar AH, El Zarif T, Khalid AB, Rahme S, Zhong C, Kwak L, Salame M, Farhat EB, Freeman D, El-Am E, Ravishankar A, Ahmad B, Nana FA, Kaldas D, Naqash AR, Sharon E, LeBoeuf NR, Cortellini A, Malgeri A, Gupta S, Al-Hader A, Sparks JA, Linnoila J, Hamnvik OR, Mouhieddine TH, Marron T, Parikh K, McKay RR, Dilling T, Choueiri TK, Adib E, Najem E, Kim SY, Sonpavde G. Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes. J Immunother Cancer. 2024 Mar 5; 12 (3) Epub 2024 Mar 05
    View PubMed
  15. Friedlaender A, Perol M, Banna GL, Parikh K, Addeo A. Oncogenic alterations in advanced NSCLC: a molecular super-highway. Biomark Res. 2024 Feb 12; 12 (1):24
    View PubMed
  16. Nassar AH, El-Am E, Denu R, Abou Alaiwi S, El Zarif T, Macaron W, Abdel-Wahab N, Desai A, Smith C, Parikh K, Abbasi M, Bou Farhat E, Williams JM, Collins JD, Al-Hader A, McKay RR, Malvar C, Sabra M, Zhong C, El Alam R, Chehab O, Lima J, Phan M, Dalla Pria HF, Trevino A, Neilan TG, Kwan JM, Ravi V, Deshpande H, Demetri G, Choueiri TK, Naqash AR. Clinical Outcomes Among Immunotherapy-Treated Patients With Primary Cardiac Soft Tissue Sarcomas: A Multicenter Retrospective Study. JACC CardioOncol. 2024 Feb; 6 (1):71-79 Epub 2024 Jan 16
    View PubMed
  17. Shanshal M, Maakaron J, Parikh K, Moffett JN, Luce AG, Schwecke AJ, Molina J, Leventakos K. Unusual outcome of treatment of thymoma with immunotherapy: case report. Mediastinum. 2024; 8:54 Epub 2024 Nov 24
    View PubMed
  18. Desai A, Smith CJ, Ashara Y, Orme JJ, Zanwar S, Potter A, Hocum C, Moffett JN, Schwecke AJ, Manochakian R, Lou Y, Zhao Y, Ernani V, Savvides P, Molina J, Dimou A, Mansfield AS, Parikh K, Leventakos K. Real-World Outcomes With Lurbinectedin in Second-Line Setting and Beyond for Extensive Stage Small Cell Lung Cancer. Clin Lung Cancer. 2023 Dec; 24 (8):689-695.e1 Epub 2023 Sept 17
    View PubMed
  19. Imbimbo M, Wetterwald L, Friedlaender A, Parikh K, Addeo A. Cellular Therapy in NSCLC: Between Myth and Reality. Curr Oncol Rep. 2023 Oct; 25 (10):1161-1174 Epub 2023 Aug 30
    View PubMed
  20. Parekh J, Parikh K, Reuss JE, Friedlaender A, Addeo A. Current Approaches to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer. Curr Oncol Rep. 2023 Aug; 25 (8):913-922 Epub 2023 May 30
    View PubMed
  21. Parikh K, Banna G, Liu SV, Friedlaender A, Desai A, Subbiah V, Addeo A. Drugging KRAS: current perspectives and state-of-art review. J Hematol Oncol. 2022 Oct 25; 15 (1):152
    View PubMed
  22. Giunta EF, Signori A, West HJ, Metro G, Friedlaender A, Parikh K, Banna GL, Addeo A. Beyond Crizotinib: A Systematic Review and Meta-Analysis of the Next-Generation ALK Inhibitors as First-Line Treatment for ALK-Translocated Lung Cancer. Front Oncol. 2022; 12:921854 Epub 2022 June 14
    View PubMed
  23. Parikh K, Hendriks LEL, Bironzo P, Remon J. Immune checkpoint inhibitors a new player in the therapeutic game of mesothelioma: New reality with new challenges. Cancer Treat Rev. 2021 Sep; 99:102250 Epub 2021 June 16
    View PubMed
  24. Asmann YW, Parikh K, Bergsagel PL, Dong H, Adjei AA, Borad MJ, Mansfield AS. Inflation of tumor mutation burden by tumor-only sequencing in under-represented groups. NPJ Precis Oncol. 2021 Mar 19; 5 (1):22
    View PubMed
  25. Uprety D, Parikh K, Sawkar A, Dimou A, Leventakos K. Changing paradigm in advanced and metastatic non-small cell lung cancer. J Thorac Dis. 2020 Nov; 12 (11):6992-7001
    View PubMed
  26. Parikh K, Mandrekar SJ, Allen-Ziegler K, Esplin B, Tan AD, Marchello B, Adjei AA, Molina JR. A Phase II Study of Pazopanib in Patients with Malignant Pleural Mesothelioma: NCCTG N0623 (Alliance). Oncologist. 2020 Jun; 25 (6):523-531 Epub 2019 Dec 24
    View PubMed
  27. Madhira BR, Konala VM, Adapa S, Naramala S, Ravella PM, Parikh K, Gentile TC. Recent Advances in the Management of Smoldering Multiple Myeloma. World J Oncol. 2020 Apr; 11 (2):45-54 Epub 2020 Mar 29
    View PubMed
  28. Parikh K, Huether R, White K, Hoskinson D, Beaubier N, Dong H, Adjei AA, Mansfield AS. Tumor Mutational Burden From Tumor-Only Sequencing Compared With Germline Subtraction From Paired Tumor and Normal Specimens. JAMA Netw Open. 2020 Feb 5; 3 (2):e200202 Epub 2020 Feb 05
    View PubMed
  29. Ram P, Tiu A, Lo KB, Parikh K, Shah M. Trends in the prevalence of malignancy among patients admitted with acute heart failure and associated outcomes: a nationwide population-based study. Heart Fail Rev. 2019 Nov; 24 (6):989-995
    View PubMed
  30. Wang S, Zimmermann S, Parikh K, Mansfield AS, Adjei AA. Current Diagnosis and Management of Small-Cell Lung Cancer. Mayo Clin Proc. 2019 Aug; 94 (8):1599-1622
    View PubMed
  31. Brumbaugh AD, Narurkar R, Parikh K, Fanucchi M, Frishman WH. Cardiac Immune-Related Adverse Events in Immune Checkpoint Inhibition Therapy. Cardiol Rev. 2019 Mar/Apr; 27 (2):97-107
    View PubMed
  32. Liu D, Mehta D, Kaur S, Kumar A, Parikh K, Chawla L, Patel S, Devi A, Saha A. Decreasing mortality and hospitalizations with rising costs related to gastric cancer in the USA: an epidemiological perspective. J Hematol Oncol. 2018 Dec 13; 11 (1):138
    View PubMed
  33. Parikh K, Kumar A, Ahmed J, Anwar A, Puccio C, Chun H, Fanucchi M, Lim SH. Peripheral monocytes and neutrophils predict response to immune checkpoint inhibitors in patients with metastatic non-small cell lung cancer. Cancer Immunol Immunother. 2018 Sep; 67 (9):1365-1370 Epub 2018 July 02
    View PubMed
  34. Shah M, Parikh K, Patel B, Agarwal M, Garg L, Agrawal S, Arora S, Patel N, Patel N, Frishman WH. Use of therapeutic hypothermia among patients with coagulation disorders - A Nationwide analysis. Resuscitation. 2018 Mar; 124:35-42 Epub 2018 Jan 03
    View PubMed
  35. Ahmed J, Kumar A, Parikh K, Anwar A, Knoll BM, Puccio C, Chun H, Fanucchi M, Lim SH. Use of broad-spectrum antibiotics impacts outcome in patients treated with immune checkpoint inhibitors. Oncoimmunology. 2018; 7 (11):e1507670 Epub 2018 Aug 20
    View PubMed
  36. Parikh K, Shah M, Mehta D, Arora S, Patel N, Liu D. Increased Mortality Among Patients With Acute Leukemia Admitted on Weekends Compared to Weekdays. Clin Lymphoma Myeloma Leuk. 2017 Dec; 17 (12):e33-e43 Epub 2017 Aug 09
    View PubMed
  37. Das A, Wei G, Parikh K, Liu D. Selective inhibitors of nuclear export (SINE) in hematological malignancies. Exp Hematol Oncol. 2015; 4:7 Epub 2015 Mar 01
    View PubMed
  38. Parikh K, Cang S, Sekhri A, Liu D. Selective inhibitors of nuclear export (SINE)--a novel class of anti-cancer agents. J Hematol Oncol. 2014 Oct 15; 7:78
    View PubMed
  39. Gupta T, Parikh K, Puri S, Agrawal S, Agrawal N, Sharma D, DeLorenzo L. The forgotten disease: Bilateral lemierre's disease with mycotic aneurysm of the vertebral artery. Am J Case Rep. 2014; 15:230-4 Epub 2014 May 25
    View PubMed
  40. Thakar K, Parikh K, Chen Y, Liu D. Isolated factor V deficiency in a patient with elevated PT and aPTT during routine pre-operative laboratory screening. Stem Cell Investig. 2014; 1:4 Epub 2014 Feb 08
    View PubMed